A phase I trial of carboplatin and Abraxane [paclitaxel] in patients with solid tumors.

Trial Profile

A phase I trial of carboplatin and Abraxane [paclitaxel] in patients with solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Mar 2012

At a glance

  • Drugs Carboplatin; Paclitaxel
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Feb 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual end date (1 Sep 2007 ) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top